20/20 #TumorBoardTuesday

Summary

Ability to detect oligomets will likely change with more use of PET-PSMA, e.g., patients with biochemical relapse but no apparent mets on conventional CT or bone scan → 74% PSMA-positive lesions
#TumorBoardTuesday